U.S.-listed medical device technology company BioSig merges with Streamex, plans to raise $1.1 billion to advance RWA tokenization development

U.S.-listed medical device technology company BioSig Technologies is merging with another publicly traded company, Streamex Exchange Corporation, while also signing a $1.1 billion financing agreement to advance the development of RWA tokenization business, promote the on-chaining of the $142 trillion commodity market, and focus on gold tokenization. The company will sell $100 million worth of senior secured convertible bonds and a $1 billion equity line of credit. Tether asset custodian Cantor Fitzgerald will serve as the joint lead placement agent for the deal. [Foresight News]